All Clinical Trials
* A Long-Term, Non-Interventional Registry to Assess Safety and Effectiveness of Humira(RegisteredTM) (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn[Single Quote]s Disease (CD) – CAPE[Double Quote]
1199.214- A double blind, randomised, placebo-controlled trial evaluating efficacy and safety of oral nintedanib treatment for at least 52 weeks in patients with [?]Systemic Sclerosis associated Interstitial Lung Disease[Single Quote](SSc-ILD).
A 24-Week Double-blind, Safety, Efficacy, and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age with Short Bowel Syndrome who are Dependent on Parenteral Support